The glycine 90 to aspartate alteration in the Aβ subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function

Genes Chromosomes and Cancer

Volumn 45, Issue 2, 2006, Pages 182-190

  Esplin, Edward D ^a   Ramos, Purita ^b   Martinez, Bobbie ^a   Tomlinson, Gail E ^a   Mumby, Marc C ^a   Evans, Glen A ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Egea Biosciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; GENOMIC DNA; GLYCINE; PHOSPHOPROTEIN PHOSPHATASE 2A;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA MICROARRAY; ENZYME SUBUNIT; GENE; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; LUNG CANCER; MALIGNANT TRANSFORMATION; MOLECULAR INTERACTION; PPP2R1B GENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; ASPARTIC ACID; BASE SEQUENCE; BREAST NEOPLASMS; DNA PRIMERS; FEMALE; GENETIC VECTORS; GLYCINE; HUMANS; IMMUNOPRECIPITATION; LUNG NEOPLASMS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIGREE; PHOSPHOPROTEIN PHOSPHATASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 31944435622     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20284     Document Type: Article

References (35)

1. Ahmadian-Tehrani M, Mumby MC, Kamibayashi C. 1996. Identification of a novel protein phosphatase 2A regulatory subunit highly expressed in muscle. J Biol Chem 271:5164-5170.
2. Andrade MA, Petosa C, O'Donoghue SI, Muller CW, Bork P. 2001. Comparison of ARM and HEAT protein repeats. J Mol Biol 309:1-18.
3. Calin GA, di Iasio MG, Caprini E, Vorechovsky I, Natali PG, Sozzi G, Croce CM, Barbanti-Brodano G, Russo G, Negrini M. 2000. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-chreonine phosphatase 2A in human neoplasms. Oncogene 19:1191-1195.
4. Campbell IG, Manolitsas T. 1999. Absence of PPP2R1B gene alterations in primary ovarian cancers. Oncogene 18:6367-6369.
5. Chen W, Possemato R, Campbell KT, Plattner CA, Pallas DC, Hahn WC. 2004. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5:127-136.
6. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. 1998. Pten . is essential for embryonic development and tumour suppression. Nat Genet 19:348-355.
7. di Iasio MG, Calin G, Tibiletti MG, Vorechovsky I, Benediktsson KP, Taramelli R, Barbanti-Brodano G, Negrini M. 1999. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene 18:1635-1638.
8. Groves MR, Hanlon N, Turowski P, Hemmings BA, Barford D. 1999. The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96:99-110.
9. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW. 1996. The tumor suppressor gene Brcal is required for embryonic cellular proliferation in the mouse. Cell 85:1009-1023.
10. Hemmer S, Wasenius VM, Haglund C, Zhu Y, Knuutila S, Franssila K, Joensuu H. 2002. Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas. Cancer Genet Cytogenet 134:13-17.
11. Hendrix P, Mayer-Jaekel RE, Cron P, Goris J, Hofsteenge J, Merlevede W, Hemmings BA. 1993. Structure and expression of a 72-kDa regulator subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. J Biol Chem 268:15267-15276.
12. Janssens V, Goris J. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353:417-439.
13. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. 2003. Cancer statistics, 2003. CA Cancer J Clin 53:5-26.
14. Kamibayashi C, Estes R, Lickteig RL, Yang S-I, Craft C, Mumby MC. 1994. Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. J Biol Chem 269:20139-20148.
15. Kerangueven F, Eisinger F, Noguchi T, Allione F, Wargniez V, Eng C, Padberg G, Theillet C, Jacquemier J, Longy M, Sobol H, Birnbaum D. 1997. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions. Oncogene 14:339-347.
16. Koreth J, Bakkenist CJ, McGee JO. 1997. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Oncogene 14:431-437.
17. Laake K, Launonen V, Niederacher D, Gudlaugsdottir S, Seitz S, Rio P, Champeme MH, Bieche I, Birnbaum D, White G, Sztan M, Sever N, Plummer S, Osorio A, Broeks A, Huusko P, Spurr N, Borg A, Cleton-Jansen AM, van't VL, Benitez J, Casey G, Peterlin B, Olah E, Borresen-Dale AL. 1999. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium. Genes Chromosomes Cancer 25:212-221.
18. McCright B, Virshup DM. 1995. Identification of a new family of protein phosphatase 2A regulatory subunits. J Biol Chem 270: 26123-26128.
19. Monaco C, Negrini M, Sozzi G, Veronese ML, Vorechovsky I, Godwin AK, Croce CM. 1997. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23. Genomics 46:217-222.
20. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK. 1995. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 55:3003-3007.
21. Pulido HA, Fakruddin MJ, Chatterjee A, Esplin ED, Beleno N, Martinez G, Posso H, Evans GA, Murty W 2000. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Cancer Res 60:6677-6682.
22. Rasio D, Negrini M, Manenti G, Dragani TA, Croce CM. 1995. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res 55:3988-3991.
23. Ruediger R, Fields K, Walter G. 1999. Binding specificity of protein phosphatase 2A core enzyme for regulatory B subunits and T antigens. J Virol 73:839-842.
24. Ruediger R, Hentz M, Fait J, Mumby M, Walter G. 1994. Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens. J Virol 68:123-129.
25. Ruediger R, Pham HT, Walter G. 2001a. Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene. Oncogene 20:1892-1899.
26. Ruediger R, Pham HT, Walter G. 2001b. Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aalpha subunit gene. Oncogene 12:10-15.
27. Takagi Y, Futamura M, Yamaguchi K, Aoki S, Takahashi T, Saji S. 2000. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers. Gut 47:268-271.
28. Takeuchi S, Cho SK, Seriu T, Koike M, Bartram CR, Reiter A, Schrappe M, Takeuchi C, Taguchi H, Koeffler HP. 1999. Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia. Oncogene 18:7387-7388.
29. Tamaki M, Goi T, Hirono Y, Katayama K, Yamaguchi A. 2004. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers. Oncol Rep 11:655-659.
30. Walter G, Mumby M. 1993. Protein serine/threonine phosphatases and cell transformation. Biochim Biophys Acta 1155:207-226.
31. Wang SS, Esplin ED, Li JL, Huang L, Gazdar A, Minna J, Evans GA. 1998. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282:284-287.
32. Wang SS, Virmani A, Gazdar AF, Minna JD, Evans GA. 1999. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer. Genes Chromosomes Cancer 25:154-159.
33. Yan Z, Fedorov SA, Mumby MC, Williams RS. 2000. PR48, a novel regulatory subunit of protein phosphatase 2a, interacts with Cdc6 and modulates DMA replication in human cells. Mol Cell Biol 20:1021-1029.
34. Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS. 2005. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. Genes Chromosomes Cancer 43:95-103.
35. Zhou J, Pham HT, Ruediger R, Walter G. 2003. Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution. Biochem J 369:387-398.